{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:51:56Z","timestamp":1792000316059,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001590","name":"Irish Health Research Board","doi-asserted-by":"crossref","award":["RP180\/2001"],"award-info":[{"award-number":["RP180\/2001"]}],"id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10096-020-04114-0","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T23:03:14Z","timestamp":1609887794000},"page":"1127-1136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antibiotic susceptibility and molecular analysis of invasive Neisseria meningitidis recovered in the Republic of Ireland, 1996 to 2016"],"prefix":"10.1007","volume":"40","author":[{"given":"D\u00e9sir\u00e9e E.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. L.","family":"Meyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"Cafferkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Cunney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"issue":"Suppl 2","key":"4114_CR1","doi-asserted-by":"publisher","first-page":"B26","DOI":"10.1016\/j.vaccine.2011.12.032","volume":"30","author":"SA Halperin","year":"2012","unstructured":"Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, McIntyre P, Ramsay ME, S\u00e1fadi MAP (2012) The changing and dynamic epidemiology of meningococcal disease. Vaccine. 30(Suppl 2):B26\u2013B36. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.032","journal-title":"Vaccine."},{"key":"4114_CR2","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1016\/j.cmi.2016.03.006","volume":"22","author":"M Sadarangani","year":"2016","unstructured":"Sadarangani M, Pollard AJ (2016) Can we control all-cause meningococcal disease in Europe? Clin Microbiol Infect 22:S103\u2013S112. https:\/\/doi.org\/10.1016\/j.cmi.2016.03.006","journal-title":"Clin Microbiol Infect"},{"key":"4114_CR3","unstructured":"Health Protection Surveillance Centre (2012) Guidelines for the early clinical and public health management of bacterial meningitis (including meningococcal disease ). Report of Scientific Advisory Committee of HPSC:1\u2013122"},{"key":"4114_CR4","doi-asserted-by":"publisher","unstructured":"Jorgensen JH, Crawford SA, Fiebelkorn KR (2005) Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents. J Clin Microbiol 43:3162\u20133171. https:\/\/doi.org\/10.1128\/JCM.43.7.3162-3171.2005","DOI":"10.1128\/JCM.43.7.3162-3171.2005"},{"key":"4114_CR5","doi-asserted-by":"publisher","unstructured":"Taha M, V\u00e1zquez JA, Hong E, Bennett DE, Bertrand S, Bukovski S, Cafferkey MT, Carion F, Christensen JJ, Diggle M, Edwards G, Enr\u00edquez R, Fazio C, Frosch M, Heuberger S, Hoffmann S, Jolley KA, Kadlubowski M, Kechrid A, Kesanopoulos K, Kriz P, Lambertsen L, Levenet I, Musilek M, Paragi M, Saguer A, Skoczy\u0144ska A, Stefanelli P, Thulin S, Tzanakaki G, Unemo M, Vogel U, Zarantonelli ML (2007) Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrobial Agents and Chemotherapy 51:2784\u20132792. https:\/\/doi.org\/10.1128\/AAC.00412-07","DOI":"10.1128\/AAC.00412-07"},{"key":"4114_CR6","doi-asserted-by":"publisher","unstructured":"Taha M, Hedberg ST, Szatanik M, Hong E, Ruckly C, Abad R, Bertrand S, Carion F, Claus H, Corso A, Enr\u00edquez R, Heuberger S, Hryniewicz W, Jolley KA, Kriz P, Mollerach M, Musilek M, Neri A, Olc\u00e9n P, Pana M, Skoczynska A, Pereira CS, Stefanelli P, Tzanakaki G, Unemo M, V\u00e1zquez JA, Vogel U, Wasko I Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing. Antimicrobial Agents and Chemotherapy 54(2010):3651\u20133658. https:\/\/doi.org\/10.1128\/AAC.00315-10","DOI":"10.1128\/AAC.00315-10"},{"key":"4114_CR7","doi-asserted-by":"publisher","unstructured":"Hong E, Thulin Hedberg S, Abad R, Fazio C, Enr\u00edquez R, Deghmane A-EA-E, Jolley KA, Stefanelli P, Unemo M, V\u00e1zquez JA, Veyrier FJ, Taha M-K (2013) Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin. Antimicrob Agents Chemother 57:1961\u20131964. https:\/\/doi.org\/10.1128\/AAC.02184-12","DOI":"10.1128\/AAC.02184-12"},{"key":"4114_CR8","doi-asserted-by":"publisher","unstructured":"B.H. Harcourt, R. Anderson, H.M. Wu, A.C. Cohn, J.R. MacNeil, T.H. Taylor, X. Wang, T.A. Clark, N.E. Messonnier, L.W. Mayer, Population-based surveillance of Neisseria meningitidis antimicrobial resistance in the United States., Open Forum Infectious Diseases. 2 (2015) ofv117. https:\/\/doi.org\/10.1093\/ofid\/ofv117","DOI":"10.1093\/ofid\/ofv117"},{"key":"4114_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/jac\/dkw400","volume":"72","author":"A-E Deghmane","year":"2017","unstructured":"Deghmane A-E, Hong E, Taha M-K (2017) Emergence of meningococci with reduced susceptibility to third-generation cephalosporins. J Antimicrob Chemother 72:95\u201398. https:\/\/doi.org\/10.1093\/jac\/dkw400","journal-title":"J Antimicrob Chemother"},{"key":"4114_CR10","doi-asserted-by":"publisher","unstructured":"T\u00f3th \u00c1, Berta B, Tirczka T, Jekkel C, \u00c1brah\u00e1m A, Proh\u00e1szka Z, Bogn\u00e1r Z, Erd\u0151si T (2017) First description of a rifampicin-resistant Neisseria meningitidis serogroup Y strain causing recurrent invasive meningococcal disease in Hungary. Acta Microbiol Immunol Hung 64:1\u20137. https:\/\/doi.org\/10.1556\/030.64.2017.006","DOI":"10.1556\/030.64.2017.006"},{"key":"4114_CR11","doi-asserted-by":"publisher","unstructured":"Hong E, Deghmane A-E, Taha M-K (2018) Acquisition of Beta-Lactamase by Neisseria meningitidis through possible horizontal gene transfer. Antimicrob Agents Chemother 62:e00831\u2013e00818. https:\/\/doi.org\/10.1128\/AAC.00831-18","DOI":"10.1128\/AAC.00831-18"},{"key":"4114_CR12","doi-asserted-by":"publisher","unstructured":"Y. Zouheir, T. Atany, N. Boudebouch, Emergence and spread of resistant N. meningitidis implicated in invasive meningococcal diseases during the past decade (2008\u20132017), The J Antibiot 72 (2019) 185\u2013188. https:\/\/doi.org\/10.1038\/s41429-018-0125-0","DOI":"10.1038\/s41429-018-0125-0"},{"key":"4114_CR13","doi-asserted-by":"publisher","unstructured":"Bennett DE, Cafferkey MT (2003) PCR and restriction endonuclease assay for detection of a novel mutation associated with sulfonamide resistance in Neisseria meningitidis. Antimicrob Agents Chemother 47:3336\u20133338. https:\/\/doi.org\/10.1128\/AAC.47.10.3336-3338.2003","DOI":"10.1128\/AAC.47.10.3336-3338.2003"},{"key":"4114_CR14","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.jadohealth.2016.04.013","volume":"59","author":"S Nadel","year":"2016","unstructured":"Nadel S (2016) Treatment of meningococcal disease. The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine 59:S21\u2013S28. https:\/\/doi.org\/10.1016\/j.jadohealth.2016.04.013","journal-title":"The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine"},{"key":"4114_CR15","doi-asserted-by":"publisher","unstructured":"European Centre for Disease Control, Surveillance of invasive bacterial diseases, in Europe 2012, 2015. https:\/\/doi.org\/10.2900\/2884","DOI":"10.2900\/2884"},{"key":"4114_CR16","doi-asserted-by":"publisher","unstructured":"Bertrand S, Carion F, Wintjens R, Mathys V, Vanhoof R (2012) Evolutionary changes in antimicrobial resistance of invasive Neisseria meningitidis isolates in Belgium from 2000 to 2010: increasing prevalence of penicillin nonsusceptibility. Antimicrob Agents Chemother 56:2268\u20132272. https:\/\/doi.org\/10.1128\/AAC.06310-11","DOI":"10.1128\/AAC.06310-11"},{"key":"4114_CR17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1473-3099(14)70806-0","volume":"14","author":"MW Bijlsma","year":"2014","unstructured":"Bijlsma MW, Bekker V, Brouwer MC, Spanjaard L, van de Beek D, van der Ende A (2014) Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data. Lancet Infect Dis 14:805\u2013812. https:\/\/doi.org\/10.1016\/S1473-3099(14)70806-0","journal-title":"Lancet Infect Dis"},{"key":"4114_CR18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1128\/AAC.01077-09","volume":"54","author":"EM Brown","year":"2010","unstructured":"Brown EM, Fisman DN, Drews SJ, Dolman S, Rawte P, Brown S, Jamieson F (2010) Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006. Antimicrob Agents Chemother 54:1016\u20131021. https:\/\/doi.org\/10.1128\/AAC.01077-09","journal-title":"Antimicrob Agents Chemother"},{"key":"4114_CR19","doi-asserted-by":"publisher","unstructured":"Hedberg ST, Fredlund H, Nicolas P, Caugant DA, Olc\u00e9n P, Unemo M (2009) Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives. Antimicrob Agents Chemother 53:1561\u20131566. https:\/\/doi.org\/10.1128\/AAC.00994-08","DOI":"10.1128\/AAC.00994-08"},{"key":"4114_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071943","volume":"8","author":"A Skoczy\u0144ska","year":"2013","unstructured":"Skoczy\u0144ska A, Wa\u015bko I, Kuch A, Kad\u0142ubowski M, Go\u0142\u0119biewska A, Fory\u015b M, Markowska M, Ronkiewicz P, Wasiak K, Kozi\u0144ska A, Matynia B, Hryniewicz W (2013) A decade of invasive meningococcal disease surveillance in Poland. PLoS One 8:e71943. https:\/\/doi.org\/10.1371\/journal.pone.0071943","journal-title":"PLoS One"},{"key":"4114_CR21","doi-asserted-by":"publisher","unstructured":"Mowlaboccus S,\u00a0Jolley KA, Bray JE, Pang S, Lee YT, Bew JD, Speers DJ, Keil AD, Coombs GW, Kahler CM (2017) Clonal expansion of new penicillin-resistant clade of Neisseria meningitidis serogroup W clonal complex 11, Australia. Emerg Infect Dis 23. https:\/\/doi.org\/10.3201\/eid2308.170259","DOI":"10.3201\/eid2308.170259"},{"key":"4114_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/antibiotics5040035","volume":"5","author":"A Zapun","year":"2016","unstructured":"Zapun A, Morlot C, Taha MK (2016) Resistance to \u03b2-lactams in neisseria ssp due to chromosomally encoded penicillin-binding proteins. Antibiotics (Basel, Switzerland) 5:35\u201347. https:\/\/doi.org\/10.3390\/antibiotics5040035","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"4114_CR23","doi-asserted-by":"publisher","unstructured":"Zalmanovici Trestioreanu A, Fraser A, Gafter-Gvili A, Paul M, Leibovici L, Cochrane Acute Respiratory Infections Group (2013) Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev 2013(10):CD004785.\u00a0https:\/\/doi.org\/10.1002\/14651858.CD004785.pub5","DOI":"10.1002\/14651858.CD004785.pub5"},{"key":"4114_CR24","first-page":"E221","volume":"40","author":"MM Lahra","year":"2016","unstructured":"Lahra MM, Enriquez RP (2016) Australian meningococcal surveillance programme annual report, 2014. Communicable Diseases Intelligence Quarterly Report 40:E221\u2013E228","journal-title":"Communicable Diseases Intelligence Quarterly Report"},{"key":"4114_CR25","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268819000396","volume":"147","author":"DE Bennett","year":"2019","unstructured":"Bennett DE, O\u2019Lorcain P, Morgan S, Cotter S, Cafferkey M, Cunney R (2019) Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data on laboratory-confirmed cases from 1996 to 2016. Epidemiol Infect 147:e142. https:\/\/doi.org\/10.1017\/s0950268819000396","journal-title":"Epidemiol Infect"},{"key":"4114_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228629","volume":"15","author":"DE Bennett","year":"2020","unstructured":"Bennett DE, Meyler KL, Cafferkey MT, Cunney RJ (2020) Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015. PLoS One 15:e0228629. https:\/\/doi.org\/10.1371\/journal.pone.0228629","journal-title":"PLoS One"},{"key":"4114_CR27","doi-asserted-by":"publisher","unstructured":"Bennett DE, Cafferkey MT (2006) Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease. J Clin Microbiol 44:1127\u20131131. https:\/\/doi.org\/10.1128\/JCM.44.3.1127-1131.2006","DOI":"10.1128\/JCM.44.3.1127-1131.2006"},{"key":"4114_CR28","doi-asserted-by":"publisher","unstructured":"Bennett DE, Mulhall RM, Cafferkey MT (2004) PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z. J Clin Microbiol 42:1764\u20131765. https:\/\/doi.org\/10.1128\/JCM.42.4.1764-1765.2004","DOI":"10.1128\/JCM.42.4.1764-1765.2004"},{"key":"4114_CR29","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1099\/0022-1317-51-10-855","volume":"51","author":"CL Trotter","year":"2002","unstructured":"Trotter CL, Fox AJ, Ramsay ME, Sadler F, Gray SJ, Mallard RH, Kaczmarski EB (2002) Fatal outcome from meningocccal disease - an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J.Med.Microbiol. 51:855\u2013860","journal-title":"J.Med.Microbiol."},{"key":"4114_CR30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","volume":"55","author":"SJ Gray","year":"2006","unstructured":"Gray SJ, Trotter CL, Ramsay ME, Guiver M, Fox AJ, Borrow R, Mallard RH, Kaczmarski EB (2006) Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the meningococcal reference unit. J Med Microbiol 55:887\u2013896. https:\/\/doi.org\/10.1099\/jmm.0.46288-0","journal-title":"J Med Microbiol"},{"key":"4114_CR31","doi-asserted-by":"publisher","unstructured":"V\u00e1zquez JA, Arreaza L, Block C, Ehrhard I, Gray SJ, Heuberger S, Hoffmann S, Kriz P, Nicolas P, Olcen P, Skoczynska A, Spanjaard L, Stefanelli P, Taha M, Tzanakaki G (2003) Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections. Antimicrob Agents Chemother 47:3430\u20133434. https:\/\/doi.org\/10.1128\/AAC.47.11.3430-3434.2003","DOI":"10.1128\/AAC.47.11.3430-3434.2003"},{"key":"4114_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1574-6976.2006.00050.x","volume":"31","author":"JA V\u00e1zquez","year":"2007","unstructured":"V\u00e1zquez JA (2007) Resistance testing of meningococci: the recommendations of the European monitoring group on meningococci. FEMS Microbiol Rev 31:97\u2013100. https:\/\/doi.org\/10.1111\/j.1574-6976.2006.00050.x","journal-title":"FEMS Microbiol Rev"},{"key":"4114_CR33","doi-asserted-by":"publisher","unstructured":"Thulin S, Olc\u00e9n P, Fredlund H, Unemo M (2006) Total variation in the penA gene of Neisseria meningitidis: correlation between susceptibility to beta-lactam antibiotics and penA gene heterogeneity. Antimicrob Agents Chemother 50:3317\u20133324. https:\/\/doi.org\/10.1128\/AAC.00353-06","DOI":"10.1128\/AAC.00353-06"},{"key":"4114_CR34","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1128\/AAC.00378-16","volume":"60","author":"N Belkacem","year":"2016","unstructured":"Belkacem N, Hong E, Antunes A, Terrade A, Deghmane A-EE, Taha M (2016) Use of animal models to support revising meningococcal breakpoints of beta-lactams. Antimicrob Agents Chemother 60:4023\u20134027. https:\/\/doi.org\/10.1128\/AAC.00378-16","journal-title":"Antimicrob Agents Chemother"},{"key":"4114_CR35","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","volume":"95","author":"MCJ Maiden","year":"1998","unstructured":"Maiden MCJ, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Zhang Q, Zhou J, Zurth K, Caugant DA, Feavers IM, Achtman M, Spratt BG (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95:3140\u20133145","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4114_CR36","doi-asserted-by":"publisher","unstructured":"Bennett DE, Cafferkey MT (2003) Multilocus restriction typing: a tool for Neisseria meningitidis strain discrimination. J Med Microbiol 52:781\u2013787. https:\/\/doi.org\/10.1099\/jmm.0.05225-0","DOI":"10.1099\/jmm.0.05225-0"},{"key":"4114_CR37","doi-asserted-by":"publisher","unstructured":"Spratt BG, Zhang QY, Jones DM, Hutchison A, Brannigan JA, Dowson CG (1989) Recruitment of a penicillin-binding protein gene from Neisseria flavescens during the emergence of penicillin resistance in Neisseria meningitidis. Proc Natl Acad Sci U S A 86:8988\u20138992. https:\/\/doi.org\/10.1073\/pnas.86.22.8988","DOI":"10.1073\/pnas.86.22.8988"},{"key":"4114_CR38","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1111\/j.1365-294X.2007.03535.x","volume":"16","author":"S Arnaud-Haond","year":"2007","unstructured":"Arnaud-Haond S, Duarte CM, Alberto F, Serr\u00e3o EA (2007) Standardizing methods to address clonality in population studies. Mol Ecol 16:5115\u20135139. https:\/\/doi.org\/10.1111\/j.1365-294X.2007.03535.x","journal-title":"Mol Ecol"},{"key":"4114_CR39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1094\/PHYTO.2003.93.6.738","volume":"93","author":"NNJ Gr\u00fcnwald","year":"2003","unstructured":"Gr\u00fcnwald NNJ, Goodwin SSB, Milgroom MG, Fry WE (2003) Analysis of genotypic diversity data for populations of microorganisms. Phytopathology. 93:738\u2013746. https:\/\/doi.org\/10.1094\/PHYTO.2003.93.6.738","journal-title":"Phytopathology."},{"key":"4114_CR40","doi-asserted-by":"publisher","unstructured":"Hedberg ST, Olc\u00e9n P, Fredlund H, Unemo M (2010) Antibiotic susceptibility of invasive Neisseria meningitidis isolates from 1995 to 2008 in Sweden---the meningococcal population remains susceptible. Scand J Infect Dis 42:61\u201364. https:\/\/doi.org\/10.3109\/00365540903292682","DOI":"10.3109\/00365540903292682"},{"key":"4114_CR41","doi-asserted-by":"publisher","unstructured":"du Plessis M, de Gouveia L, Skosana H, Thomas J, Blumberg L, Klugman KP, von Gottberg A (2010) Invasive Neisseria meningitidis with decreased susceptibility to fluoroquinolones in South Africa, 2009. J Antimicrob Chemother 65:2258\u20132260. https:\/\/doi.org\/10.1093\/jac\/dkq291","DOI":"10.1093\/jac\/dkq291"},{"key":"4114_CR42","doi-asserted-by":"crossref","unstructured":"I. Mounchetrou Njoya, A.-E. Deghmane, M. Taha, H. Isnard, I. Parent du Chatelet, A cluster of meningococcal disease caused by rifampicin-resistant C meningococci in France, April 2012., Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 17 (2012) 1\u20133","DOI":"10.2807\/ese.17.34.20254-en"},{"key":"4114_CR43","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1099\/jmm.0.078600-0","volume":"63","author":"B Zhu","year":"2014","unstructured":"Zhu B, Fan Y, Xu Z, Xu L, Du P, Gao Y, Shao Z (2014) Genetic diversity and clonal characteristics of ciprofloxacin-resistant meningococcal strains in China. J Med Microbiol 63:1411\u20131418. https:\/\/doi.org\/10.1099\/jmm.0.078600-0","journal-title":"J Med Microbiol"},{"key":"4114_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM (2014) Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 27:587\u2013613. https:\/\/doi.org\/10.1128\/CMR.00010-14","journal-title":"Clin Microbiol Rev"},{"key":"4114_CR45","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/1471-2105-11-595","volume":"11","author":"KA Jolley","year":"2010","unstructured":"Jolley KA, Maiden MCJ (2010) BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595. https:\/\/doi.org\/10.1186\/1471-2105-11-595","journal-title":"BMC Bioinformatics"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04114-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-04114-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04114-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T14:17:09Z","timestamp":1621606629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-04114-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["4114"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-04114-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"25 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"<i>N. meningitidis<\/i> isolates were received as part of routine activity of the IMSRL for performing national surveillance of invasive meningococcal disease in the Republic of Ireland and were analysed anonymously.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have approved the manuscript and agree to its submission to European Journal of Clinical Microbiology and Infectious Diseases.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}